Skip to main content
Thomas Keane, MD, Urology, Charleston, SC

Thomas E Keane MD

Surgical Oncology


Professor of Urology, Chairman of Department. Medical University of South Carolina.

Join to View Full Profile
  • 171 Ashley AveCharleston, SC 29425

  • Phone+1 843-792-1414

  • Fax+1 843-792-4870

Dr. Keane is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Chairman of the department of urology since 2002
    Expanded the faculty from 4 to 14 attendings, and the residency from 6 to 15 residents, Established 2 Fellowships: Female pelvic health and reconstruction and Advanced oncologic surgical training.
    Established 3 endowed chairs and multiple funded research Grants.

Education & Training

  • Duke University Hospital
    Duke University HospitalResidency, Urology, 1988 - 1993
  •  Surgical fellowship training scheme
    Surgical fellowship training schemeFellowship, 1983 - 1986
  • University College of Dublin National Univ SOM
    University College of Dublin National Univ SOMClass of 1981

Certifications & Licensure

  • SC State Medical License
    SC State Medical License 2002 - 2025
  • FL State Medical License
    FL State Medical License 2013 - 2019
  • GA State Medical License
    GA State Medical License 1993 - 2009
  • NC State Medical License
    NC State Medical License 1989 - 1993
  • Urology
    American Board of Urology Urology

Awards, Honors, & Recognition

  • Member of the Academic Association of European urologists EAU.
  • editor of 5th,6th,7th and 8th editions of Glenns Urologic Surgery -Textbook
  • America's Top Doctor US News and World Report
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Precision Incisions: Minimally Invasive Techniques in Genitourinary Cancer
    Precision Incisions: Minimally Invasive Techniques in Genitourinary CancerOctober 15th, 2019
  • RADAR II Group Recommendations - the Role of Therapeutic Layering
    RADAR II Group Recommendations - the Role of Therapeutic LayeringMay 23rd, 2018
  • Discussion of the IMmotion 151 Trial: Atezolizumab plus Bevacizumab vs Sunitinib in Untreated Metastatic Renal Cell Carcinoma - Thomas Keane
    Discussion of the IMmotion 151 Trial: Atezolizumab plus Bevacizumab vs Sunitinib in Untreated Metastatic Renal Cell Carcinoma - Thomas KeaneJune 6th, 2020

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: